期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

厄洛替尼导致眼睫毛异常生长一例报告并文献复习 被引量：2

原文传递
导出
摘要 1病例报告 患者女,61岁。因“查体发现右肺上叶占位3d”于2013-05-21就诊山东中医药大学附属医院。患者胸闷、憋喘,时觉胸痛,咳嗽频发。既往有冠心病、高血压病史10余年,服用药物不详,血压（140~150）/（85~95）mm Hg。否认家族遗传病史,否认疫水、放射性物质及化学物质接触史。颈部、腋窝及腹股沟区未触及肿大淋巴结。胸廓对称无异常,右肺呼吸音低.
作者 徐鹏 李秀荣
机构地区 山东中医药大学第一临床医学院 山东中医药大学附属医院肿瘤科
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第23期1848-1849,1855,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 表皮生长因子抑制剂 厄洛替尼 维持治疗 睫毛异常生长
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Maemondo M,Inoue A,Kobayashi K, et al. Gefitinib or chemo therapy for non-small-cell lung cancer with mutated EGFR]-J. N Engl J Meal,2010,362(25) :2380-2388.
  • 2Hong J, Kyung SY, Lee SP, et al. Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancer. [J]. Korean J Intern Med,2010,25(3) :294-300.
  • 3马晓丽,张建清,杨媚,白鸽,张莉.厄洛替尼维持治疗晚期非小细胞肺癌的系统评价[J].中华肿瘤防治杂志,2014,21(10):786-791. 被引量：17
  • 4Takeda M,Okamoto I,Nakagawa K. Pooled safety analysis of EGFR TKI treatment for EGFR mutation-positive nowsmall cell hmg canc- er[J]. Lung Cancer,2015,88(1) :74-79.
  • 5Gerber PA, Homey B. Images in clinical medicine. Erlotinib- induced hair alteratlons[J]. N Engl J Med,2008,358(113:1175.
  • 6Sugawara K, Schneider MR, Dahlhoff M, et al. Cutaneous conse- quences of inhibiting EGF receptor signaling in vivo: normal hairfollicle development, but retarded hair cycle induction and inhibi tion of adipocyte growth in Egfr(WaS) mice[J]. J Dermatol Sci, 2010,57(3) :155-161.
  • 7Lupu I, Voiculescu VM, Bacalbasa N, et al. Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors [J].J Med Life, 2015,8:57-61.
  • 8Jeon SH, Ryu JS, Choi OS, et al. Erlotinib induced trichomegaly of the eyelashes[J]. Tubere Respir Dis (Seoul), 2013,74 (1) : 37-40.
  • 9Ocvirk J, Cencelj S. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic eoloreetal cancer [J]. J Eur Acad Dermatol Venereol,2010, 24(4):453 459.
  • 10Goel V, Raina S, Chandragouda D, et al. Trichomegaly of eye- lashes after treatment with erlotinib in carcinoma pancreas[J]. Int J Trichology, 2014,6 (1) : 23-24.

二级参考文献15

  • 1Stineheombe TE,Soeinki MA. Treatment paradigms for advanced stage non small cell lung cancer in the era of multiple lines of therapy[J]. J Thoracic Oncol, 2009,4 (2) : 243-250.
  • 2Cappuzzo F, Ciuleanu T, Stelmakh L, et al. Erlotinib as mainte- nance treatment in advanced non-small-cell lung cancer: amulti- centre,randomised, placebo controlled phase 3 study[J]. Lanct OncoL,2010,11 (6) :521 -529.
  • 3Perol M, Chouaid C, Milleron BJ, et al. Maintenance with either gem- citabine or erlotinib versus observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy in ad- vanced NSCLC: IFCT-GFPC 0502 phase III study[J]. J Clin Oncol (meeting abstracts), 2010,28(20) : 7507-7512.
  • 4Parmar MK,Torri V, Stewart L, et al. Extracting summary sta- tistics to perform meta-analysis of the published literature for survival endpoints[J]. Stat Med, 1998,17 (24) : 2815-2834.
  • 5Altman DG, Bland JM. Interaction revisited: the. difference be tween two estimates[J]. BMJ,2003,326(7382) :219-224.
  • 6Mok TS, Wu YL, Yu CJ, et al. Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first- line treatment for advanced non-small-cell lung cancer[J]. J Clin Oncol,2009,27(30) :5080 5087.
  • 7Kabbinavar FF, Miller VA, Johnson BE, et al. Overall survival (OS) in ATLAS, a phase m b trial comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy (chemo) with B for first-line treatment of locally advanced, recur- rent,or metastatic non-small cell lung cancer (NS(2LC)[J]. J Clin Oncol (meeting abstracts) ,2010,28(4) :7526 -7530.
  • 8Herbst RS, Prager D, Hermann R, et al. TRIBUTE Investigator Group:TRIBUTE:a phase lli trial of erlotinib hydrochloride(OSI- 774) combined with earboplatin and paelitaxel chemo~therapy in ad- vanced non-small cell lung cancer [J]. J Clin Oneol, 2005,23 (25) : 5892-5899.
  • 9Egger M,Davey SG,Schneider M,et al. Bias in meta analysis de- tected by a simple, graphical test[J]. BMJ, 1997,315(7109) : 629- 634.
  • 10Higgins JP, Thompson SG, Deeks J J, et al. Measuringineonsistency in Meta-analyses[J]. BMJ, 2003,327 (7414) : 557-560.

共引文献16

同被引文献7

引证文献2

二级引证文献1

中华肿瘤防治杂志
2015年 第23期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部